GGrantIndex
Sort

21,453 grants matching tuberculosis

SP-A Receptor Modulation of Macrophage Phagocytosis

$220,793
University Of Texas Hlth Ctr At Tyler · R01 · FY2002 · HL

SP-A Receptor Modulation of Macrophage Phagocytosis

$220,793
University Of Texas Hlth Ctr At Tyler · R01 · FY2003 · HL

Structural and functional studies of a PhoP-PhoR two-component system

$220,594
Shuishu Wang · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2008 · GM

ORAL DISSOLVING STRIPS FOR THE DELIVERY OF ISONIAZID IN CHILDREN AND ADULTS

$220,582
Steve Bobzin · Oak Therapeutics, Inc. · N01 · FY2016 · AI

Infectious Disease Training in Clinical Investigation

$220,549
James R Johnson · University Of Minnesota · T32 · FY2011 · AI

New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosis

$220,530
Maha Farhat · Harvard Medical School · K01 · FY2018 · ES

Recognition of Mtb-infected cells by CD8+ T lymphocytes

$220,500
David M. Lewinsohn · Oregon Health & Science University · R01 · FY2014 · AI

Recognition of Mtb-infected cells by CD8+ T lymphocytes

$220,500
David M. Lewinsohn · Oregon Health & Science University · R01 · FY2015 · AI

Tuberculosis in diabetic guinea pigs

$220,500
Randall J Basaraba · Colorado State University · R21 · FY2012 · AI

Recognition of Mtb-infected cells by CD8+ T lymphocytes

$220,500
David M. Lewinsohn · Oregon Health & Science University · R01 · FY2016 · AI

Targeting persistent M. tuberculosis through the inhibition of its aldolase

$220,500
Mary Jackson · Colorado State University · R21 · FY2009 · AI

Recognition of Mtb-infected cells by CD8+ T lymphocytes

$220,500
David M. Lewinsohn · Oregon Health & Science University · R01 · FY2012 · AI

Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)

$220,447
Jessica L Castilho · Vanderbilt University Medical Center · U01 · FY2025 · AI

Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)

$220,424
Chris Todd Longenecker · University Of Washington · R01 · FY2025 · HL

Ultra-Sensitive Diagnosis of AIDS-Related Tuberculosis

$220,230
Gerard A Cangelosi · Attodx, Inc. · R41 · FY2015 · AI

Mtb-Catalyzed Cholesterol Oxidation as Virulence Factor

$220,222
Nicole S. Sampson · State University New York Stony Brook · R21 · FY2006 · AI

Molecular Biology

$220,207
Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2022 · GM

Monocyte subpopulation in HIV+LTB+ individuals and development of active TB

$220,014
Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R21 · FY2016 · AI

Inhaled pyrazinoic acid for tuberculosis therapy

$220,013
Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2018 · AI

Individualized approaches to the HIV/TB epidemic among polysubstance users in Irkutsk

$220,000
Scott K Heysell · University Of Virginia · R01 · FY2019 · DA

Investigating the role of liquid-liquid phase separation in the interaction between Mycobacterium tuberculosis and macrophages

$220,000
Samantha Lynn Bell · Rbhs-New Jersey Medical School · DP2 · FY2022 · AI

Novel and Optimized Diagnostics for Pediatric TB

$219,999
Jerrold J. Ellner · Rbhs-New Jersey Medical School · R01 · FY2022 · AI

Novel and Optimized Diagnostics for Pediatric TB

$219,999
Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI

Bacteria and Host in TB Transmission

$219,999
David Alland · Rbhs-New Jersey Medical School · R01 · FY2022 · AI

HIV, TB, HSV 2--EMERGENCE OF DRUG RESISTANCE

$219,993
University Of California Los Angeles · R01 · FY2000 · AI